Common approaches include the 16/8 protocol (16-hour fast, 8-hour eating window), the 5:2 method (eating normally five days, restricting calories two days), or eat-stop-eat protocols (24-hour fasts once or twice weekly)
Complementary Therapies in Clinical Practice, 22 , 4450
The FDA has also raised concerns about unapproved GLP-1 products, including: Incorrect dosing or measurement Concentration differences between pharmacies Use of unapproved semaglutide salt forms Products containing too much or too little active ingredient Fraudulent or improperly labelled products Adverse events related to compounded injections Patients should confirm the pharmacy name, drug concentration, prescribed dose and measurement instructions before administering each shipment
Holst (2007)
doi: 10.1152/ajpcell.00093.2003
Obesity Science & Innovation Sep 24, 2026 TO Sep 25, 2025 | Boston, MA The Obesity Science & Innovation event drives the future of obesity therapeutics by bringing together the most innovative companies with the right partners